Action potential duration is an important determinant of refractorines
s in cardiac tissue and thus of the ability to propagate electrical im
pulses. Action potential duration is controlled in part by activation
of K+ currents. Block of K+ channels and the resultant prolongation of
action potential duration has become an increasingly attractive mode
of antiarrhythmic intervention. Detailed investigation of individual c
ardiac K+ channels has been hampered by the presence of multiple types
of K+ channels in cardiac cells and the difficulty of isolating indiv
idual currents. We have approached this problem by employing a combina
tion molecular cloning technology, heterologous channel expression sys
tems, and biophysical analysis of expressed channels. We have focused
on six different channels cloned from the rat and human cardiovascular
systems. Each channel has unique functional and pharmacological chara
cteristics, and is a group they comprise a series of mammalian K+ chan
nel isoforms that can account for some of the diversity of channels in
the mammalian heart. Each channel appears to be encoded by a differen
t gene with little or no evidence for alternate splicing of RNA transc
ripts to account for the differences in primary amino acid sequence. I
n addition to the unique kinetic properties of these channel isoforms
when expressed as homotetrameric assemblies, the formation of heterote
trameric K+ channels is also observed. The formation of heterotetramer
ic channels from the different gene products to create new channels wi
th unique kinetic and pharmacological properties might further account
for cardiac K+ channel diversity.